I don't think it is a question of "when" but if. In order

New Post Public Reply Private Reply Replies (1) Message Board
yuggibeht rth #6147

I don't think it is a question of "when" but if. In order to understand that, we have to understand "why". I see two possible reasons why a company would purchase a P2O system from JBI; ROI (business reasons), and PR purposes (being a green company).

The green angle is similar to why a VP of Sustainable development would buy a Nissan Leaf. I stopped by a dealer some time back and test drive one. Nice little car. Needs an overdrive, but nice little car for getting around town. Lots of drawbacks, needs more range and a network of recharging stations.

Now, for a VP of Sustainable Development to have a vehicle like that would be good for Nissan and for the company. Otherwise, it makes no economic sense for the average person. But, it makes a statement. Likewise, a company with a JBI processor would improve it's image.

Now, the reason why most companies buy systems like this is because of an ROI. It is simply not there. I just did a calculation assuming a capital cost of 4%, an initial cost of 2 Million, and cash profits of 15k/ quarter over 3 years. That is the profitability from p2O last quarter. In that scenario, the capital cost is not even paid, and forget about making any money. They need an ROI of over 20% in order to sell for business reasons. That is, take the Capital Cost to build, add to it operating costs over 3 years, and revenues must exceed that by 20%.

They have to be ready to sell as well. They would need a modular unit that is constructible and fully documented. There would have to be a set of engineering plans such that any construction company could build it.

If they sell a processor for PR reasons, I would guess they might get 500k for it. It might be a good way of closing down the Niagara site, which is just costing Heddle money. Move the unit to some company to at last carry the JBI name forward. I believe at that point they would have to carry that amount on the books as well, as the value of P&E is the lesser of market or cost?

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading